Cutting	O
edge	O
:	O
expression	O
of	O
the	O
NF	B-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
in	O
eosinophils	B-cell_type
:	O
regulation	O
by	O
IL-4	B-protein
and	O
IL-5	B-protein
.	O

We	O
report	O
that	O
NF-AT1	B-protein
and	O
NF-AT4	B-protein
are	O
expressed	O
cytoplasmically	O
in	O
resting	B-cell_type
eosinophils	I-cell_type
,	O
whereas	O
NF-AT2	B-protein
and	O
NF-AT3	B-protein
have	O
not	O
been	O
seen	O
.	O

Likewise	O
,	O
NF-AT1	B-RNA
mRNA	I-RNA
and	O
NF-AT4	B-RNA
mRNA	I-RNA
have	O
been	O
detected	O
in	O
resting	B-cell_type
eosinophils	I-cell_type
,	O
and	O
their	O
levels	O
can	O
be	O
significantly	O
up-regulated	O
by	O
the	O
Th2-associated	B-protein
cytokines	I-protein
IL-4	B-protein
and	O
IL-5	B-protein
.	O

There	O
is	O
no	O
detectable	O
NF-AT	B-protein
protein	O
expression	O
in	O
the	O
nuclei	O
of	O
resting	B-cell_type
eosinophils	I-cell_type
.	O

However	O
NF-ATs	B-protein
appear	O
in	O
the	O
nuclei	O
of	O
IL-4-	B-cell_line
,	I-cell_line
IL-5-	I-cell_line
,	I-cell_line
or	I-cell_line
ionomycin-stimulated	I-cell_line
eosinophils	I-cell_line
.	O

Only	O
NF-AT1	B-protein
and	O
NF-AT4	B-protein
,	O
but	O
not	O
NF-AT2	B-protein
and	O
NF-AT3	B-protein
,	O
have	O
translocated	O
into	O
the	O
nuclei	O
in	O
IL-4-	B-cell_line
or	I-cell_line
IL-5-stimulated	I-cell_line
eosinophils	I-cell_line
.	O

These	O
findings	O
delineate	O
a	O
novel	O
pathway	O
in	O
the	O
cytokine	O
network	O
in	O
which	O
Th2	B-cell_line
lymphocytes	I-cell_line
``	O
control	O
''	O
eosinophils	B-cell_type
via	O
the	O
release	O
of	O
IL-4	B-protein
and	O
IL-5	B-protein
,	O
and	O
activation	O
of	O
NF-AT	B-protein
in	O
eosinophils	B-cell_type
.	O

The	O
findings	O
also	O
suggest	O
that	O
a	O
later	O
feedback	O
``	O
talking	O
''	O
may	O
exist	O
between	O
eosinophils	B-cell_type
and	O
Th2	B-cell_line
lymphocytes	I-cell_line
.	O

.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
A	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
“	NULL
CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
nso	NULL
wop	NULL
ms	NULL
GSS	NULL
A	NULL
F	NULL
,	NULL
(	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Ain	NULL
meJournal	NULL
of	NULL
Cutting	NULL
Edge	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
NF	NULL
of	NULL
*	NULL
Immunolo	NULL
gy	NULL
Activated	NULL
T	NULL
Cells	NULL
in	NULL
Eosinophils	NULL
:	NULL
Regulation	NULL
by	NULL
IL-4	NULL
and	NULL
IL-5	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Tan	NULL
Jinquan	NULL
,	NULL
Sha	NULL
Quan	NULL
,	NULL
Henrik	NULL
H.	NULL
Jacobi	NULL
,	NULL
Claus	NULL
M.	NULL
Reimert	NULL
,	NULL
of	NULL
11512121	NULL
,	NULL
2181136	NULL
$	NULL
8	NULL
Is	NULL
current	NULL
as	NULL
Anders	NULL
Millner	NULL
,	NULL
Jens	NULL
B.	NULL
Hansen	NULL
,	NULL
Charlotte	NULL
Thygesen	NULL
,	NULL
Lars	NULL
P.	NULL
'	NULL
Ryder	NULL
,	NULL
Hans	NULL
O.	NULL
Madsen	NULL
,	NULL
Hans-Jgrgen	NULL
Malling	NULL
and	NULL
Lars	NULL
K.	NULL
Poulsen	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:21-24	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
13	NULL
articles	NULL
,	NULL
7	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/1/21	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*e	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'Ot	NULL
Aept	NULL
uo	NULL
1san3	NULL
4g	NULL
/810founwrurt	NULL
[	NULL
'mmmy	NULL
,	NULL
/	NULL
:	NULL
dyy	NULL
wos	NULL
(	NULL
CTIDG	NULL
€	NULL
am	NULL
m	NULL
Cutting	NULL
Edge	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
NF	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
in	NULL
Eosinophils	NULL
:	NULL
Regulation	NULL
by	NULL
IL-4	NULL
and	NULL
IL-5	NULL
``	NULL
Tan	NULL
Jinquan,2	NULL
>	NULL
l	NULL
<	NULL
Sha	NULL
Quan	NULL
,	NULL
*	NULL
Henrik	NULL
H.	NULL
Jacobi	NULL
,	NULL
*	NULL
Claus	NULL
M.	NULL
Reimert	NULL
,	NULL
*	NULL
Anders	NULL
Millner	NULL
,	NULL
*	NULL
Jens	NULL
B.	NULL
Hansen	NULL
,	NULL
*	NULL
Charlotte	NULL
Thygesen	NULL
,	NULL
*	NULL
Lars	NULL
P.	NULL
Ryder	NULL
,	NULL
``	NULL
Hans	NULL
O.	NULL
Madsen	NULL
,	NULL
``	NULL
Hans-Jgrgen	NULL
Malling	NULL
,	NULL
*	NULL
and	NULL
Lars	NULL
K.	NULL
Poulsen	NULL
``	NULL
*	NULL
We	NULL
report	NULL
that	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
are	NULL
expressed	NULL
cytoplasmically	NULL
in	NULL
resting	NULL
eosinophils	NULL
,	NULL
whereas	NULL
NF-AT2	NULL
and	NULL
NF-AT3	NULL
have	NULL
not	NULL
been	NULL
seen	NULL
.	NULL

Likewise	NULL
,	NULL
NF-AT1	NULL
mRNA	NULL
and	NULL
NF-AT4	NULL
mRNA	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
resting	NULL
eosinophils	NULL
,	NULL
and	NULL
their	NULL
levels	NULL
can	NULL
be	NULL
significantly	NULL
up-regulated	NULL
by	NULL
the	NULL
Th2-associated	NULL
cytokines	NULL
IL-4	NULL
and	NULL
IL-5	NULL
.	NULL

There	NULL
is	NULL
no	NULL
detectable	NULL
NF-AT	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
resting	NULL
eosinophils	NULL
.	NULL

However	NULL
NF-ATs	NULL
appear	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
IL-4-	NULL
,	NULL
IL-5-	NULL
,	NULL
or	NULL
ionomycin-stimu-lated	NULL
eosinophils	NULL
.	NULL

Only	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
,	NULL
but	NULL
not	NULL
NF-AT2	NULL
and	NULL
NF-AT3	NULL
,	NULL
have	NULL
translocated	NULL
into	NULL
the	NULL
nuclei	NULL
in	NULL
IL-4-	NULL
or	NULL
IL-5-stimulated	NULL
eosinophils	NULL
.	NULL

These	NULL
findings	NULL
delineate	NULL
a	NULL
novel	NULL
pathway	NULL
in	NULL
the	NULL
cytokine	NULL
network	NULL
in	NULL
which	NULL
Th2	NULL
lymphocytes	NULL
``	NULL
con-trol	NULL
``	NULL
eosinophils	NULL
via	NULL
the	NULL
release	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
.	NULL

The	NULL
findings	NULL
also	NULL
suggest	NULL
that	NULL
a	NULL
later	NULL
feedback	NULL
``	NULL
talking	NULL
``	NULL
may	NULL
exist	NULL
between	NULL
eosinophils	NULL
and	NULL
Th2	NULL
lymphocytes	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
:	NULL
21-24.	NULL
uclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cytokine	NULL
and	NULL
early	NULL
immune	NULL
response	NULL
gene	NULL
expression	NULL
.	NULL

NF-AT1-defi-cient	NULL
mice	NULL
are	NULL
prone	NULL
to	NULL
developing	NULL
a	NULL
classically	NULL
allergic	NULL
phenotype	NULL
characterized	NULL
by	NULL
eosinophilia	NULL
and	NULL
increased	NULL
production	NULL
of	NULL
Th2-associated	NULL
cytokines	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
have	NULL
allergic	NULL
blepharitis	NULL
,	NULL
interstitial	NULL
pneumonitis	NULL
,	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
serum	NULL
IgG1	NULL
and	NULL
IgE	NULL
levels	NULL
,	NULL
secondary	NULL
to	NULL
a	NULL
selective	NULL
increase	NULL
in	NULL
Th2-associated	NULL
cytokines	NULL
(	NULL
2	NULL
)	NULL
.	NULL

NF-AT	NULL
proteins	NULL
are	NULL
expressed	NULL
not	NULL
only	NULL
in	NULL
*Laboratory	NULL
of	NULL
Medical	NULL
Allergology	NULL
,	NULL
Allergy	NULL
Unit	NULL
,	NULL
and	NULL
*Laboratory	NULL
of	NULL
Tissue	NULL
Typing	NULL
,	NULL
Department	NULL
of	NULL
Clinical	NULL
Immunology	NULL
,	NULL
National	NULL
University	NULL
Hospital	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
1	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
30	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

TJ	NULL
.	NULL

,	NULL
S.Q	NULL
.	NULL

,	NULL
and	NULL
A.M.	NULL
are	NULL
supported	NULL
by	NULL
generous	NULL
grants	NULL
from	NULL
the	NULL
Danish	NULL
Allergy	NULL
Research	NULL
Center	NULL
and	NULL
from	NULL
the	NULL
Alfred	NULL
Benzons	NULL
Foundation	NULL
.	NULL

°	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Drs	NULL
.	NULL

Tan	NULL
Jinquan	NULL
or	NULL
Lars	NULL
K.	NULL
Poulsen	NULL
,	NULL
Laboratory	NULL
of	NULL
Medical	NULL
Allergology	NULL
,	NULL
Finsen	NULL
Center	NULL
7542	NULL
,	NULL
National	NULL
University	NULL
Hospital	NULL
,	NULL
Tagensvej	NULL
20	NULL
,	NULL
DK-2200	NULL
Copenhagen	NULL
N	NULL
,	NULL
Denmark	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
TAN	NULL
@	NULL
RH.DK	NULL
or	NULL
Ikpallgy	NULL
@	NULL
inct.uni2.dk	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
T	NULL
lymphocytes	NULL
but	NULL
also	NULL
in	NULL
other	NULL
cells	NULL
including	NULL
B	NULL
lymphocytes	NULL
,	NULL
NK	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
thymus	NULL
and	NULL
spleen	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
whether	NULL
NF-AT	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
eosinophils	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
expression	NULL
of	NULL
NF-AT	NULL
proteins	NULL
and	NULL
the	NULL
corresponding	NULL
mRNA	NULL
in	NULL
peripheral	NULL
eosinophils	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
these	NULL
proteins	NULL
by	NULL
IL-4	NULL
and	NULL
IL-5	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Purification	NULL
of	NULL
eosinophils	NULL
Eosinophils	NULL
were	NULL
purified	NULL
from	NULL
healthy	NULL
,	NULL
nonallergic	NULL
volunteers	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
Percoll	NULL
gradient	NULL
(	NULL
1.082	NULL
g/ml	NULL
;	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
was	NULL
used	NULL
to	NULL
enrich	NULL
eosinophils	NULL
;	NULL
anti-CD16-coated	NULL
MACS	NULL
magnetic	NULL
particles	NULL
(	NULL
Miltenyi	NULL
Biotech	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Ger-many	NULL
)	NULL
were	NULL
used	NULL
to	NULL
deplete	NULL
neutrophils	NULL
.	NULL

Eosinophil	NULL
purity	NULL
was	NULL
invariably	NULL
=97	NULL
%	NULL
(	NULL
lymphocytes	NULL
<	NULL
0.5	NULL
%	NULL
)	NULL
.	NULL

The	NULL
whole	NULL
procedure	NULL
was	NULL
conducted	NULL
at	NULL
4°C	NULL
in	NULL
a	NULL
Ca	NULL
``	NULL
*	NULL
-free	NULL
and	NULL
Mg**-free	NULL
medium	NULL
.	NULL

Immunocytochemistry	NULL
assay	NULL
The	NULL
purified	NULL
eosinophils	NULL
were	NULL
spun	NULL
down	NULL
on	NULL
a	NULL
slide	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
immersed	NULL
in	NULL
1	NULL
%	NULL
BSA	NULL
blocking	NULL
buffer	NULL
for	NULL
10	NULL
min	NULL
to	NULL
avoid	NULL
unspecific	NULL
binding	NULL
;	NULL
next	NULL
,	NULL
primary	NULL
Ab	NULL
(	NULL
20	NULL
ug/ml	NULL
of	NULL
either	NULL
anti-NF-AT1	NULL
(	NULL
mouse	NULL
mAb	NULL
4G6-G5	NULL
)	NULL
,	NULL
anti-NF-AT2	NULL
(	NULL
mouse	NULL
mAb	NULL
7A6	NULL
)	NULL
,	NULL
anti-NF-AT3	NULL
(	NULL
goat	NULL
pAb°	NULL
C-20	NULL
)	NULL
,	NULL
or	NULL
anti-NF-AT4	NULL
(	NULL
goat	NULL
pAb	NULL
C-20	NULL
)	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Eosinophils	NULL
were	NULL
then	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
secondary	NULL
Ab	NULL
,	NULL
and	NULL
were	NULL
visualized	NULL
by	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
staining	NULL
system	NULL
(	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Real	NULL
time	NULL
quantitative	NULL
RT-PCR	NULL
assay	NULL
All	NULL
real	NULL
time	NULL
quantitative	NULL
RT-PCRs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
and	NULL
submitted	NULL
to	NULL
real	NULL
time	NULL
quantitative	NULL
PCR	NULL
in	NULL
an	NULL
ABI	NULL
Prism	NULL
7700	NULL
Sequence	NULL
Detector	NULL
System	NULL
(	NULL
Per-kin-Elmer	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

By	NULL
using	NULL
a	NULL
SYBR	NULL
Green	NULL
PCR	NULL
Core	NULL
Reagents	NULL
Kit	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
,	NULL
fluorescence	NULL
signals	NULL
were	NULL
generated	NULL
during	NULL
each	NULL
PCR	NULL
cycle	NULL
via	NULL
the	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
endonuclease	NULL
activity	NULL
of	NULL
AmpliTaq	NULL
Gold	NULL
to	NULL
provide	NULL
real	NULL
time	NULL
quantitative	NULL
PCR	NULL
information	NULL
.	NULL

The	NULL
following	NULL
sequences	NULL
of	NULL
the	NULL
specific	NULL
primers	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
U.K.	NULL
)	NULL
were	NULL
used	NULL
:	NULL
NF-AT1	NULL
sense	NULL
,	NULL
NF-AT1	NULL
antisense	NULL
,	NULL
5'-TGGTTGCCCTCATGTTGTTTTT-3	NULL
'	NULL
;	NULL
NF-AT2	NULL
sense	NULL
,	NULL
CGCAGCACCCCTACCAGT-3	NULL
'	NULL
;	NULL
NF-AT2	NULL
antisense	NULL
,	NULL
5'-TTCITTCCTC	NULL
CCGATGTCCGTCTCT-3	NULL
'	NULL
;	NULL
NF-AT3	NULL
sense	NULL
,	NULL
5-GGTTTCCCGGCCAGT	NULL
CCAGGTCTA-3	NULL
'	NULL
;	NULL
NF-AT3	NULL
antisense	NULL
,	NULL
5'-AAGGGGCGGGGAAGGAAG	NULL
GAAACT-3	NULL
'	NULL
;	NULL
NF-AT4	NULL
sense	NULL
,	NULL
5-ACCAGCCCGGGAGACTTCAATA	NULL
GA-3	NULL
'	NULL
;	NULL
NF-AT4	NULL
antisense	NULL
,	NULL
5'-AAATACCTGCACAATCAATACTGG-3	NULL
'	NULL
.	NULL

°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
pAb	NULL
,	NULL
polyclonal	NULL
Ab	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
Ton	NULL
,	NULL
ionomycin	NULL
;	NULL
NF-AT	NULL
hulL-2	NULL
,	NULL
distal	NULL
NF-AT	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
;	NULL
C4	NULL
,	NULL
threshold	NULL
cycle	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
22	NULL
FIGURE	NULL
1	NULL
.	NULL

Distribution	NULL
of	NULL
NF-AT	NULL
proteins	NULL
in	NULL
resting	NULL
eosinophils	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
either	NULL
anti-NF-AT1	NULL
(	NULL
A	NULL
)	NULL
,	NULL
anti-NF-AT2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
anti-NF-AT3	NULL
(	NULL
C	NULL
)	NULL
,	NULL
anti-NF-AT4	NULL
(	NULL
D	NULL
)	NULL
,	NULL
isotype	NULL
mouse	NULL
IgG2a	NULL
(	NULL
£	NULL
)	NULL
,	NULL
or	NULL
goat	NULL
serum	NULL
(	NULL
F	NULL
)	NULL
.	NULL

The	NULL
eosinophils	NULL
were	NULL
cytoplasmically	NULL
stained	NULL
with	NULL
Abs	NULL
of	NULL
mouse	NULL
anti-NF-AT1	NULL
(	NULL
A	NULL
)	NULL
and	NULL
goat	NULL
anti-NF-AT4	NULL
(	NULL
D	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
arrow	NULL
in	NULL
B	NULL
indicates	NULL
a	NULL
contaminating	NULL
T	NULL
lymphocyte	NULL
(	NULL
morphologically	NULL
identified	NULL
)	NULL
that	NULL
was	NULL
very	NULL
seldom	NULL
seen	NULL
in	NULL
the	NULL
preparations	NULL
(	NULL
<	NULL
0.5	NULL
%	NULL
)	NULL
.	NULL

This	NULL
unique	NULL
cell	NULL
has	NULL
been	NULL
considered	NULL
as	NULL
a	NULL
good	NULL
internal	NULL
positive	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
photographed	NULL
under	NULL
X400	NULL
magnification	NULL
.	NULL

The	NULL
target	NULL
cDNA	NULL
was	NULL
adjusted	NULL
to	NULL
amounts	NULL
equal	NULL
to	NULL
those	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
(	NULL
G-actin	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

PCRs	NULL
were	NULL
optimized	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
15	NULL
s	NULL
at	NULL
95°C	NULL
and	NULL
60	NULL
s	NULL
at	NULL
60°C	NULL
with	NULL
40	NULL
cycles	NULL
for	NULL
each	NULL
amplification	NULL
.	NULL

To	NULL
express	NULL
the	NULL
results	NULL
,	NULL
two	NULL
terms	NULL
were	NULL
used	NULL
:	NULL
AR	NULL
,	NULL
,	NULL
representing	NULL
the	NULL
normalized	NULL
reporter	NULL
signal	NULL
minus	NULL
the	NULL
baseline	NULL
signal	NULL
established	NULL
in	NULL
the	NULL
first	NULL
few	NULL
cycles	NULL
PCR	NULL
,	NULL
and	NULL
C	NULL
;	NULL
(	NULL
thresh-old	NULL
cycle	NULL
)	NULL
,	NULL
representing	NULL
the	NULL
PCR	NULL
cycle	NULL
at	NULL
which	NULL
an	NULL
increase	NULL
in	NULL
reporter	NULL
fluorescence	NULL
signal	NULL
above	NULL
a	NULL
baseline	NULL
can	NULL
first	NULL
be	NULL
detected	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

and	NULL
Aram-buru	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
400	NULL
ul	NULL
of	NULL
ice-cold	NULL
Dignam	NULL
buffer	NULL
A	NULL
and	NULL
then	NULL
25	NULL
jl	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
were	NULL
added	NULL
into	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
vortexed	NULL
and	NULL
centrifuged	NULL
(	NULL
9000	NULL
rpm	NULL
,	NULL
30	NULL
s	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
lysed	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
Dignam	NULL
buffer	NULL
C	NULL
and	NULL
centrifuged	NULL
(	NULL
12,000	NULL
rpm	NULL
,	NULL
10	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
;	NULL
the	NULL
resulting	NULL
supernatants	NULL
were	NULL
diluted	NULL
(	NULL
1/1	NULL
)	NULL
with	NULL
Dignam	NULL
buffer	NULL
D.	NULL
Double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
DNA	NULL
probes	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
(	NULL
5000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
,	NULL
one	NULL
strand	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
:	NULL
human	NULL
IL-2	NULL
distal	NULL
NF-AT	NULL
site	NULL
(	NULL
NF-AT	NULL
hullL-2	NULL
)	NULL
,	NULL
GGAGGAAAAACTGTTTCATACAGAAGG	NULL
(	NULL
binding	NULL
sequences	NULL
are	NULL
underlined	NULL
)	NULL
;	NULL
consensus	NULL
AP-1	NULL
site	NULL
,	NULL
CGCTTGATGACT	NULL
CAGCCGGAA	NULL
.	NULL

EMSA	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
25	NULL
ul	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
3	NULL
ug	NULL
of	NULL
protein	NULL
per	NULL
reaction	NULL
volume	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
8	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
0.5	NULL
ng	NULL
P-labeled	NULL
probes	NULL
to	NULL
react	NULL
for	NULL
15	NULL
min	NULL
;	NULL
next	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
nondenatured	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
buffer	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
cold	NULL
probes	NULL
used	NULL
as	NULL
competitors	NULL
were	NULL
added	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
reaction	NULL
to	NULL
identical	NULL
aliquots	NULL
of	NULL
the	NULL
extracts	NULL
(	NULL
100-fold	NULL
higher	NULL
than	NULL
labeled	NULL
probes	NULL
)	NULL
.	NULL

The	NULL
mAbs	NULL
used	NULL
for	NULL
supershift	NULL
(	NULL
all	NULL
at	NULL
10	NULL
ug/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
.	NULL

CUTTING	NULL
EDGE	NULL
ARn	NULL
(	NULL
.	NULL

~	NULL
10°	NULL
Q	NULL
}	NULL
#	NULL
ZW	NULL
30	NULL
(	NULL
cycle	NULL
)	NULL
y2	NULL
/d	NULL
104	NULL
}	NULL
?	NULL

S	NULL
+	NULL
MTV/	NULL
(	NULL
y	NULL
Fi	NULL
0	NULL
15	NULL
30	NULL
(	NULL
cycle	NULL
)	NULL
10°	NULL
iC	NULL
10°	NULL
10	NULL
[	NULL
p	NULL
ARn	NULL
ARn	NULL
107	NULL
``	NULL
~24	NULL
s	NULL
wif	NULL
.	NULL

i	NULL
.	NULL

,	NULL
R	NULL
&	NULL
<	NULL
7	NULL
mem	NULL
0	NULL
15	NULL
50	NULL
|_	NULL
D	NULL
40	NULL
as	NULL
30	NULL
(	NULL
cycle	NULL
)	NULL
£	NULL
nek	NULL
.	NULL

¥*t.	NULL
a_	NULL
20	NULL
10	NULL
10	NULL
)	NULL
_	NULL
10	NULL
-	NULL
10	NULL
CT	NULL
r-remm-orm-rromi	NULL
104	NULL
(	NULL
S	NULL
.	NULL

Q	NULL
.	NULL
)	NULL

FIGURE	NULL
2	NULL
.	NULL

Plots	NULL
of	NULL
the	NULL
real	NULL
time	NULL
detection	NULL
and	NULL
amplification	NULL
of	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT	NULL
in	NULL
resting	NULL
and	NULL
IL-4-	NULL
and	NULL
IL-5-stimulated	NULL
eosinophils	NULL
.	NULL

A	NULL
,	NULL
Crs	NULL
are	NULL
19.5	NULL
for	NULL
the	NULL
standard	NULL
DNA	NULL
template	NULL
(	NULL
2.0	NULL
X	NULL
10°	NULL
copies	NULL
for	NULL
B-actin	NULL
,	NULL
black	NULL
)	NULL
,	NULL
26.1	NULL
for	NULL
NF-AT1	NULL
mRNA	NULL
(	NULL
orange	NULL
)	NULL
,	NULL
>	NULL
40	NULL
for	NULL
NF-AT2	NULL
(	NULL
red	NULL
)	NULL
and	NULL
NF-AT3	NULL
(	NULL
blue	NULL
)	NULL
,	NULL
and	NULL
28.5	NULL
for	NULL
NF-AT4	NULL
(	NULL
green	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
Orange	NULL
plots	NULL
represent	NULL
the	NULL
amplification	NULL
of	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT1	NULL
in	NULL
resting	NULL
eosinophils	NULL
.	NULL

C	NULL
;	NULL
s	NULL
are	NULL
22.9	NULL
for	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT1	NULL
in	NULL
IL-4-stimulated	NULL
eosinophils	NULL
(	NULL
pink	NULL
)	NULL
and	NULL
24.5	NULL
for	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT1	NULL
in	NULL
IL-5-stimulated	NULL
eosinophils	NULL
(	NULL
blue	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Green	NULL
plots	NULL
represent	NULL
the	NULL
amplification	NULL
of	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT4	NULL
in	NULL
resting	NULL
eosinophils	NULL
.	NULL

C	NULL
;	NULL
s	NULL
are	NULL
24.5	NULL
for	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT4	NULL
in	NULL
IL-4-stimulated	NULL
eosinophils	NULL
(	NULL
pink	NULL
)	NULL
and	NULL
23.8	NULL
for	NULL
the	NULL
mRNA	NULL
of	NULL
NF-AT4	NULL
in	NULL
IL-5-stimulated	NULL
eosinophils	NULL
(	NULL
blue	NULL
)	NULL
.	NULL

D	NULL
,	NULL
Linear	NULL
relationship	NULL
between	NULL
Cp	NULL
and	NULL
log	NULL
starting	NULL
quantity	NULL
(	NULL
S	NULL
.	NULL

Q	NULL
.	NULL
)	NULL

of	NULL
the	NULL
standard	NULL
DNA	NULL
template	NULL
(	NULL
black	NULL
circles	NULL
)	NULL
or	NULL
target	NULL
(	NULL
NF-AT1	NULL
or	NULL
NF-AT4	NULL
)	NULL
mRNA	NULL
(	NULL
red	NULL
circles	NULL
)	NULL
.	NULL

The	NULL
correlation	NULL
coefficient	NULL
is	NULL
0.886	NULL
.	NULL

The	NULL
plots	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
performed	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Expression	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
By	NULL
immunocytochemistry	NULL
assay	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
NF-AT1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
NF-AT4	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
are	NULL
cytoplasmically	NULL
expressed	NULL
in	NULL
resting	NULL
eosinophils	NULL
.	NULL

NF-AT2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
NF-AT3	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
have	NULL
not	NULL
been	NULL
detected	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
,	NULL
E	NULL
and	NULL
F	NULL
,	NULL
are	NULL
the	NULL
mouse	NULL
and	NULL
goat	NULL
isotype	NULL
Ab	NULL
negative	NULL
control	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
a	NULL
tendency	NULL
for	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
the	NULL
nuclei	NULL
in	NULL
IL-4-	NULL
and	NULL
IL-5-activated	NULL
eosinophils	NULL
.	NULL

NF-AT	NULL
's	NULL
have	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

mRNA	NULL
of	NULL
the	NULL
NF-AT	NULL
family	NULL
are	NULL
expressed	NULL
in	NULL
eosinophils	NULL
and	NULL
regulated	NULL
by	NULL
IL-4	NULL
and	NULL
IL-5	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
mRNA	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
resting	NULL
eosinophils	NULL
;	NULL
NF-AT2	NULL
and	NULL
NF-AT3	NULL
mRNA	NULL
have	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

There	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
&	NULL
¢	NULL
J	NULL
f	NULL
Stimulus	NULL
*	NULL
NFAT	NULL
A	NULL
Lane	NULL
C.	NULL
Comp	NULL
.	NULL

O	NULL
©	NULL
©	NULL
O	NULL
)	NULL
O	NULL
®	NULL
O	NULL
)	NULL
®	NULL
®	NULL
$	NULL
)	NULL
.plb	NULL
yp	NULL
o	NULL
4	NULL
Stimulus	NULL
g	NULL
&	NULL
¢	NULL
JQ	NULL
’	NULL
N	NULL
?	NULL

N°°	NULL
Q	NULL
?	NULL

Q	NULL
?	NULL

NFAT	NULL
|	NULL
B	NULL
Lane	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
NF-AT	NULL
activation	NULL
in	NULL
eosinophils	NULL
upon	NULL
IL-4	NULL
and	NULL
IL-5	NULL
stimulation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
(	NULL
B	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Eosinophils	NULL
were	NULL
freshly	NULL
isolated	NULL
(	NULL
None	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-5	NULL
(	NULL
10	NULL
ng/ml1	NULL
)	NULL
,	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
(	NULL
0.1	NULL
ug/ml	NULL
,	NULL
H	NULL
indicates	NULL
a	NULL
cell	NULL
prestimulation	NULL
with	NULL
IL-4	NULL
10	NULL
ng/ml	NULL
for	NULL
1	NULL
h	NULL
)	NULL
,	NULL
or	NULL
Ion	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

NF-AT	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
NF-AT	NULL
hullL-2	NULL
probe	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
Identical	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
eosinophils	NULL
stimulated	NULL
without	NULL
(	NULL
None	NULL
)	NULL
or	NULL
with	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
or	NULL
Ion	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
as	NULL
competitor	NULL
(	NULL
C	NULL
.	NULL

Comp	NULL
.	NULL
)	NULL

before	NULL
the	NULL
addition	NULL
of	NULL
*°P-labeled	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
.	NULL

#	NULL
indicates	NULL
where	NULL
cold	NULL
AP-1	NULL
site	NULL
probes	NULL
were	NULL
applied	NULL
.	NULL

X	NULL
indicates	NULL
where	NULL
a	NULL
**P-labeled	NULL
AP-1	NULL
site	NULL
probe	NULL
was	NULL
applied	NULL
.	NULL

The	NULL
expression	NULL
and	NULL
activation	NULL
of	NULL
AP-1	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

«	NULL
__	NULL
sa	NULL
__se	NULL
_	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
1708	NULL
9	NULL
are	NULL
~1.9	NULL
X	NULL
10°	NULL
copies	NULL
for	NULL
NF-AT1	NULL
and	NULL
~6.7	NULL
X	NULL
10°	NULL
copies	NULL
for	NULL
NF-AT4	NULL
in	NULL
the	NULL
resting	NULL
eosinophils	NULL
,	NULL
whereas	NULL
no	NULL
copies	NULL
coding	NULL
NF-AT2	NULL
and	NULL
NF-AT3	NULL
have	NULL
been	NULL
found	NULL
within	NULL
40	NULL
cycles	NULL
.	NULL

NF-AT1	NULL
mRNA	NULL
have	NULL
been	NULL
significantly	NULL
up-regulated	NULL
in	NULL
IL-4-	NULL
and	NULL
IL-5-stimulated	NULL
(	NULL
all	NULL
at	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

eosinophils	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

There	NULL
are	NULL
~6.4	NULL
X	NULL
10°	NULL
copies	NULL
and	NULL
~5	NULL
X	NULL
10°	NULL
copies	NULL
for	NULL
NF-AT1	NULL
,	NULL
respectively	NULL
.	NULL

NF-AT4	NULL
mRNA	NULL
have	NULL
also	NULL
been	NULL
significantly	NULL
up-regulated	NULL
in	NULL
the	NULL
IL-4-	NULL
and	NULL
IL-5-stimulated	NULL
eosinophils	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

There	NULL
are	NULL
~3.0	NULL
X	NULL
10°	NULL
copies	NULL
and	NULL
~4.4	NULL
X	NULL
10°	NULL
copies	NULL
for	NULL
NF-AT4	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
linear	NULL
relationship	NULL
between	NULL
C	NULL
;	NULL
and	NULL
log	NULL
starting	NULL
quantity	NULL
of	NULL
the	NULL
standard	NULL
DNA	NULL
template	NULL
or	NULL
target	NULL
cDNA	NULL
(	NULL
NF-AT1	NULL
and	NULL
NF-AT4	NULL
)	NULL
has	NULL
been	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
that	NULL
NF-AT1	NULL
,	NULL
NF-AT2	NULL
,	NULL
NF-AT3	NULL
,	NULL
and	NULL
NF-AT4	NULL
have	NULL
been	NULL
expressed	NULL
in	NULL
purified	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
their	NULL
expression	NULL
can	NULL
be	NULL
up-regulated	NULL
by	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4-	NULL
and	NULL
IL-5-induced	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
There	NULL
is	NULL
no	NULL
detectable	NULL
NF-AT	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
resting	NULL
eosinophils	NULL
.	NULL

NF-AT	NULL
hulL-2	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
IL-4-	NULL
or	NULL
IL-5-stimulated	NULL
(	NULL
1	NULL
h	NULL
)	NULL
eosinophils	NULL
,	NULL
which	NULL
indicates	NULL
that	NULL
IL-4	NULL
and	NULL
IL-5	NULL
can	NULL
induce	NULL
NF-AT	NULL
activation	NULL
,	NULL
resulting	NULL
a	NULL
translocation	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Ionomycin	NULL
(	NULL
Ion	NULL
)	NULL
(	NULL
0.1	NULL
ug/	NULL
ml	NULL
)	NULL
also	NULL
activates	NULL
NF-AT	NULL
to	NULL
nuclear	NULL
translocation	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
0.1	NULL
g/m	NULL
!	NULL
)	NULL

is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
activation	NULL
of	NULL
NF-AT	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

NF-AT	NULL
complexes	NULL
in	NULL
IL-4-	NULL
,	NULL
IL-5-	NULL
,	NULL
or	NULL
Ion-stimulated	NULL
eosinophils	NULL
have	NULL
been	NULL
completely	NULL
and	NULL
specifically	NULL
competed	NULL
by	NULL
a	NULL
100-fold	NULL
23	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
°_	NULL
___	NULL
30	NULL
120	NULL
Stimulus	NULL
$	NULL
09	NULL
é°	NULL
V	NULL
V	NULL
$	NULL
0	NULL
v	NULL
)	NULL
V	NULL
$	NULL
0°J	NULL
NY	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
._	NULL
15	NULL
30	NULL
120	NULL
Stimulus	NULL
Coy	NULL
¢8J	NULL
¢	NULL
sy	NULL
$	NULL
wai	NULL
.u-	NULL
``	NULL
,	NULL
ari	NULL
Ma	NULL
-	NULL
w	NULL
Antibody	NULL
(	NULL
-	NULL
)	NULL
(	NULL
-	NULL
)	NULL
(	NULL
i	NULL
)	NULL
1	NULL
2	NULL
1.2	NULL
(	NULL
-	NULL
)	NULL
1	NULL
2	NULL
1.2	NULL
sinue	NULL
#	NULL
*5	NULL
5	NULL
¢	NULL
¢	NULL
5	NULL
of	NULL
of	NULL
E	NULL
E	NULL
E	NULL
Lane	NULL
C	NULL
20	NULL
3	NULL
40	NULL
50	NULL
60	NULL
708	NULL
9	NULL
10	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Kinetics	NULL
of	NULL
NF-AT	NULL
activation	NULL
in	NULL
IL-4-	NULL
and	NULL
IL-5-stimulated	NULL
eosinophils	NULL
and	NULL
identification	NULL
of	NULL
NF-AT1	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
eosinophils	NULL
.	NULL

Eosinophils	NULL
were	NULL
freshly	NULL
isolated	NULL
(	NULL
None	NULL
)	NULL
,	NULL
stimulated	NULL
in	NULL
medium	NULL
(	NULL
None	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
or	NULL
IL-5	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
.	NULL

Kinetics	NULL
of	NULL
NFE-AT	NULL
activation	NULL
and	NULL
AP-1	NULL
were	NULL
assessed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
(	NULL
A	NULL
)	NULL
or	NULL
an	NULL
AP-1	NULL
probe	NULL
(	NULL
B	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Eosinophils	NULL
were	NULL
freshly	NULL
isolated	NULL
(	NULL
None	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
or	NULL
IL-5	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
NF-AT1	NULL
and	NULL
NF-AT2	NULL
was	NULL
done	NULL
by	NULL
using	NULL
mAb	NULL
(	NULL
s	NULL
)	NULL
toward	NULL
NF-AT1	NULL
and/or	NULL
NF-AT2	NULL
and	NULL
EMSA	NULL
in	NULL
supershift	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Before	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
°°P-labeled	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
,	NULL
identical	NULL
aliquots	NULL
of	NULL
samples	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
isotype	NULL
mouse	NULL
IgG	NULL
(	NULL
i	NULL
)	NULL
,	NULL
mouse	NULL
anti-human	NULL
NF-AT1	NULL
mAb	NULL
(	NULL
1	NULL
)	NULL
,	NULL
mouse	NULL
anti-human	NULL
NF-AT2	NULL
mAb	NULL
(	NULL
2	NULL
)	NULL
,	NULL
or	NULL
NF-AT1	NULL
mAb	NULL
plus	NULL
NF-AT2	NULL
mAb	NULL
(	NULL
1.2	NULL
)	NULL
.	NULL

NF-AT	NULL
binding	NULL
to	NULL
P-labeled	NULL
NF-AT	NULL
hulL-2	NULL
and	NULL
the	NULL
supershift	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
mAbs	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
lower	NULL
and	NULL
upper	NULL
arrow-heads	NULL
,	NULL
respectively	NULL
.	NULL

molar	NULL
excess	NULL
of	NULL
the	NULL
cold	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
,	NULL
whereas	NULL
no	NULL
competition	NULL
is	NULL
induced	NULL
by	NULL
the	NULL
cold	NULL
AP-1	NULL
site	NULL
probe	NULL
.	NULL

A	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
cold	NULL
AP-1	NULL
site	NULL
probe	NULL
can	NULL
completely	NULL
and	NULL
specifically	NULL
compete	NULL
the	NULL
°°P-labeled	NULL
AP-1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
why	NULL
the	NULL
cold	NULL
AP-1	NULL
site	NULL
probe	NULL
does	NULL
not	NULL
compete	NULL
the	NULL
NF-AT	NULL
hulL-2	NULL
probe	NULL
in	NULL
our	NULL
experiments	NULL
,	NULL
because	NULL
the	NULL
binding	NULL
complex	NULL
probably	NULL
contains	NULL
both	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

NF-AT	NULL
translocation	NULL
into	NULL
the	NULL
nuclei	NULL
of	NULL
IL-4-	NULL
and	NULL
IL-5-stimulated	NULL
eosinophils	NULL
has	NULL
been	NULL
detected	NULL
within	NULL
15	NULL
min	NULL
and	NULL
lasts	NULL
for	NULL
=120	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
AP-1	NULL
was	NULL
seen	NULL
in	NULL
freshly	NULL
isolated	NULL
eosinophils	NULL
;	NULL
increased	NULL
activity	NULL
of	NULL
AP-1	NULL
in	NULL
nuclei	NULL
of	NULL
eosinophils	NULL
after	NULL
stimulation	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
24	NULL
(	NULL
?	NULL
)	NULL

A	NULL
B	NULL
®	NULL
<	NULL
=	NULL
Th2	NULL
cells	NULL
|	NULL
n	NULL
2	NULL
|	NULL
3	NULL
#	NULL
|	NULL
-	NULL
Eosinophils	NULL
|	NULL
H	NULL
]	NULL
J	NULL
*	NULL
B	NULL
mummmmmmmeml	NULL
)	NULL
A	NULL
Gomme	NULL
FIGURE	NULL
5	NULL
.	NULL

A	NULL
schematic	NULL
view	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
and	NULL
Th2	NULL
lymphocytes	NULL
.	NULL

A	NULL
represents	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
NF-AT	NULL
.	NULL

B	NULL
represents	NULL
an	NULL
inactivated	NULL
form	NULL
of	NULL
NF-AT	NULL
.	NULL

with	NULL
IL-4	NULL
or	NULL
IL-5	NULL
was	NULL
observed	NULL
for	NULL
120	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

NF-AT1	NULL
complex	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
mouse	NULL
anti-NF-AT1	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Neither	NULL
isotype	NULL
mouse	NULL
IgG	NULL
nor	NULL
mouse	NULL
anti-NF-AT2	NULL
mAb	NULL
can	NULL
affect	NULL
the	NULL
relative	NULL
mobility	NULL
of	NULL
the	NULL
NF-AT	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
NF-AT1	NULL
,	NULL
but	NULL
not	NULL
NF-AT2	NULL
,	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
IL-4-	NULL
or	NULL
IL-5-activated	NULL
eosinophils	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
NF-AT4	NULL
,	NULL
but	NULL
not	NULL
NF-AT3	NULL
,	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
IL-4-	NULL
or	NULL
IL-S-activated	NULL
eosinophils	NULL
has	NULL
also	NULL
been	NULL
confirmed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
and	NULL
IL-5	NULL
induce	NULL
the	NULL
appearance	NULL
of	NULL
NF-AT	NULL
's	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
eosinophils	NULL
is	NULL
unknown	NULL
,	NULL
because	NULL
the	NULL
cytokines	NULL
are	NULL
not	NULL
known	NULL
to	NULL
induce	NULL
a	NULL
Ca**	NULL
influx	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-AT	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
further	NULL
investigate	NULL
this	NULL
mechanism	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
entire	NULL
band	NULL
is	NULL
supershifted	NULL
with	NULL
anti-NF-AT1	NULL
.	NULL

This	NULL
finding	NULL
seems	NULL
to	NULL
be	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
conclusions	NULL
for	NULL
NF-AT4	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
phenomenon	NULL
may	NULL
be	NULL
that	NULL
the	NULL
NF-AT4	NULL
content	NULL
in	NULL
eosinophils	NULL
is	NULL
so	NULL
small	NULL
that	NULL
the	NULL
NF-AT1	NULL
band	NULL
overlaps	NULL
the	NULL
NF-AT4	NULL
band	NULL
.	NULL

In	NULL
mice	NULL
lacking	NULL
NF-AT1	NULL
,	NULL
resulting	NULL
an	NULL
in	NULL
vivo	NULL
model	NULL
of	NULL
allergic	NULL
inflammation	NULL
,	NULL
an	NULL
increased	NULL
pleural	NULL
accumulation	NULL
of	NULL
eosinophils	NULL
and	NULL
serum	NULL
IgE	NULL
levels	NULL
and	NULL
an	NULL
abnormal	NULL
pattern	NULL
of	NULL
IL-4	NULL
gene	NULL
expression	NULL
are	NULL
seen	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
eosinophilia	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
serum	NULL
IgE	NULL
in	NULL
these	NULL
mice	NULL
are	NULL
apparently	NULL
dependent	NULL
upon	NULL
the	NULL
overproduction	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
NF-AT4	NULL
have	NULL
impaired	NULL
development	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
single-positive	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
hyperactivation	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
mentioned	NULL
above	NULL
suggest	NULL
that	NULL
the	NULL
NF-AT	NULL
family	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
inducible	NULL
gene	NULL
transcription	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
allergic	NULL
response	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
eosinophils	NULL
,	NULL
one	NULL
of	NULL
the	NULL
key	NULL
cells	NULL
in	NULL
allergic	NULL
inflammation	NULL
,	NULL
may	NULL
not	NULL
only	NULL
be	NULL
a	NULL
passive	NULL
target	NULL
for	NULL
the	NULL
deficiency	NULL
,	NULL
dysfunc-tion	NULL
,	NULL
or	NULL
inactivation	NULL
of	NULL
the	NULL
NF-AT	NULL
family	NULL
in	NULL
Th2	NULL
lymphocytes	NULL
,	NULL
but	NULL
may	NULL
also	NULL
be	NULL
an	NULL
active	NULL
regulator	NULL
during	NULL
the	NULL
initiation	NULL
,	NULL
development	NULL
,	NULL
limitation	NULL
,	NULL
and	NULL
termination	NULL
of	NULL
allergic	NULL
inflammation	NULL
.	NULL

Kiani	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
NF-AT1	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
down-regulating	NULL
the	NULL
late	NULL
phase	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription-inhibiting	NULL
Th2	NULL
CUTTING	NULL
EDGE	NULL
responses	NULL
.	NULL

This	NULL
is	NULL
evidence	NULL
that	NULL
NF-AT	NULL
proteins	NULL
regulate	NULL
not	NULL
only	NULL
the	NULL
initiation	NULL
but	NULL
also	NULL
the	NULL
termination	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
in	NULL
support	NULL
of	NULL
this	NULL
observation	NULL
in	NULL
light	NULL
of	NULL
the	NULL
biological	NULL
functions	NULL
of	NULL
eosinophils	NULL
and	NULL
Th2	NULL
lymphocytes	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
results	NULL
,	NULL
we	NULL
might	NULL
propose	NULL
that	NULL
NF-AT	NULL
could	NULL
be	NULL
deficient	NULL
or	NULL
genetically	NULL
inactivated	NULL
in	NULL
certain	NULL
circumstances	NULL
such	NULL
as	NULL
allergic	NULL
conditions	NULL
.	NULL

A	NULL
challenge	NULL
such	NULL
as	NULL
allergen	NULL
stimulation	NULL
initiates	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
of	NULL
allergic	NULL
inflammation	NULL
,	NULL
including	NULL
overproduction	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
activation	NULL
of	NULL
eosinophils	NULL
,	NULL
and	NULL
eosinophilia	NULL
.	NULL

An	NULL
over-release	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
could	NULL
subsequently	NULL
activate	NULL
NF-AT	NULL
in	NULL
eosinophils	NULL
.	NULL

The	NULL
cascade	NULL
of	NULL
biological	NULL
events	NULL
in	NULL
eosinophils	NULL
after	NULL
NF-AT	NULL
activation	NULL
would	NULL
result	NULL
in	NULL
later	NULL
feedback	NULL
``	NULL
talking	NULL
``	NULL
to	NULL
Th2	NULL
lymphocytes	NULL
to	NULL
induce	NULL
secondary	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
the	NULL
Th2	NULL
lymphocytes	NULL
(	NULL
may	NULL
also	NULL
be	NULL
other	NULL
types	NULL
of	NULL
immune	NULL
cells	NULL
)	NULL
.	NULL

This	NULL
later	NULL
feedback	NULL
talking	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
termination	NULL
of	NULL
allergic	NULL
disorders	NULL
.	NULL

A	NULL
schematic	NULL
view	NULL
for	NULL
this	NULL
proposal	NULL
is	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

It	NULL
will	NULL
be	NULL
quite	NULL
interesting	NULL
to	NULL
investigate	NULL
the	NULL
exact	NULL
mechanism	NULL
of	NULL
the	NULL
secondary	NULL
activation	NULL
of	NULL
NF-AT	NULL
in	NULL
Th2	NULL
lymphocytes	NULL
during	NULL
the	NULL
later	NULL
feedback	NULL
talking	NULL
on	NULL
the	NULL
pathway	NULL
in	NULL
the	NULL
cytokine	NULL
network	NULL
between	NULL
eosinophils	NULL
and	NULL
Th2	NULL
lymphocytes	NULL
,	NULL
especially	NULL
in	NULL
cells	NULL
from	NULL
allergic	NULL
subjects	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Lisbeth	NULL
Abrahamsen	NULL
and	NULL
Ulla	NULL
Minuva	NULL
for	NULL
their	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Viola	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
A.	NULL
Kiani	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
allergic	NULL
inflammation	NULL
and	NULL
eosinophil	NULL
recruitment	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
:	NULL
role	NULL
of	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-5	NULL
.	NULL

Blood	NULL
91:2223	NULL
.	NULL

2	NULL
.	NULL

Ranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
Oukka	NULL
,	NULL
J.	NULL
Rengarajan	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1998	NULL
.	NULL

Inhibitory	NULL
function	NULL
of	NULL
two	NULL
NFAT	NULL
family	NULL
members	NULL
in	NULL
lymphoid	NULL
homeostasis	NULL
and	NULL
Th2	NULL
de-velopment	NULL
.	NULL

Immunity	NULL
9:627	NULL
.	NULL

3	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:707	NULL
.	NULL

4	NULL
.	NULL

Boss	NULL
,	NULL
V.	NULL
,	NULL
K.	NULL
L.	NULL
Abbott	NULL
,	NULL
X.	NULL
F.	NULL
Wang	NULL
,	NULL
G.	NULL
K.	NULL
Pavlath	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Murphy	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
cyclosporin	NULL
A-sensitive	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
:	NULL
differential	NULL
localization	NULL
of	NULL
NFAT	NULL
isoforms	NULL
and	NULL
induction	NULL
of	NULL
NFAT-mediated	NULL
transcription	NULL
by	NULL
phospholipase	NULL
C-coupled	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:19664	NULL
.	NULL

5	NULL
.	NULL

Hansel	NULL
T.	NULL
T.	NULL
,	NULL
I.	NULL
J.	NULL
De-Vries	NULL
,	NULL
T.	NULL
Iff	NULL
,	NULL
S.	NULL
Rihs	NULL
,	NULL
M.	NULL
Wandzilak	NULL
,	NULL
S.	NULL
Betz	NULL
,	NULL
K.	NULL
Blaser	NULL
,	NULL
and	NULL
C.	NULL
Walker	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
improved	NULL
immunomagnetic	NULL
procedure	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
highly	NULL
purified	NULL
human	NULL
blood	NULL
eosinophils	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
12:105	NULL
.	NULL

6	NULL
.	NULL

Kruse	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Pette	NULL
,	NULL
K.	NULL
Toyka	NULL
,	NULL
and	NULL
P.	NULL
Rieckmann	NULL
.	NULL

1997	NULL
.	NULL

Quantification	NULL
of	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
by	NULL
RT	NULL
PCR	NULL
in	NULL
samples	NULL
of	NULL
previously	NULL
frozen	NULL
blood	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
210:195	NULL
.	NULL

7	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
C.	NULL
Jamieson	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
nuclear	NULL
factor	NULL
resembling	NULL
NF-AT	NULL
binds	NULL
to	NULL
an	NULL
NF-KB	NULL
site	NULL
and	NULL
to	NULL
the	NULL
conserved	NULL
lympho-kine	NULL
promoter	NULL
sequence	NULL
``	NULL
cytokine-1	NULL
.	NULL
``	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:1864	NULL
.	NULL

8	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
,	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
regulation	NULL
upon	NULL
CD16	NULL
ligand	NULL
binding	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:801	NULL
.	NULL

9	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
preexisting	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:837	NULL
.	NULL

10	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
.	NULL

11	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Y	NULL
.	NULL

Show	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
D.	NULL
C.	NULL
Luk	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892	NULL
.	NULL

12	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:397	NULL
.	NULL

13	NULL
.	NULL

Oukka	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NFAT4	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
and	NULL
survival	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
9:295	NULL
.	NULL

14	NULL
.	NULL

Kiani	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

Down-regulation	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription	NULL
and	NULL
control	NULL
of	NULL
Th2	NULL
cell	NULL
differentiation	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
NFAT1	NULL
.	NULL

Immunity	NULL
7:849	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL

